Maxime Rousseaux, PhD, is an Assistant Professor and Canada Research Chair at the University of Ottawa. He obtained his PhD in neuroscience under Dr. David Park’s supervision in Ottawa. There his research had focused on identifying mechanisms of neurodegeneration in mouse models of Parkinson’s disease (PD). In 2012, Dr. Rousseaux joined Dr. Huda Zoghbi’s laboratory at Baylor College of Medicine to pursue a postdoctoral fellowship. During that time, he focused on identifying novel regulators of alpha-synuclein levels using forward genetic screens to gain novel therapeutic entry points for synucleinopathy disorders. In 2018, he was recruited back to the University of Ottawa to start his own lab with a focus on studying how protein mislocalization may be linked to neurodegenerative diseases such as Parkinson’s. His group has an affinity for generating new mouse models that depict aspects of PD and examining how genetic and environmental factors converge on PD etiology.
Co-Investigator
Maxime Rousseaux, PhD
University of Ottawa
Maxime Rousseaux, PhD, is an Assistant Professor and Canada Research Chair at the University of Ottawa. He obtained his PhD in neuroscience under Dr. David Park’s supervision in Ottawa. There his research had focused on identifying mechanisms of neurodegeneration in mouse models of Parkinson’s disease (PD). In 2012, Dr. Rousseaux joined Dr. Huda Zoghbi’s laboratory at Baylor College of Medicine to pursue a postdoctoral fellowship. During that time, he focused on identifying novel regulators of alpha-synuclein levels using forward genetic screens to gain novel therapeutic entry points for synucleinopathy disorders. In 2018, he was recruited back to the University of Ottawa to start his own lab with a focus on studying how protein mislocalization may be linked to neurodegenerative diseases such as Parkinson’s. His group has an affinity for generating new mouse models that depict aspects of PD and examining how genetic and environmental factors converge on PD etiology.
